Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients with colorectal peritoneal metastasis who undergoing palliative chemotherapy?-Reference-Cited by-同舟云学术

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients with colorectal peritoneal metastasis who undergoing palliative chemotherapy?

Published:2024-01 Issue:1 Volume:47 Page:296-302
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Cho Hye Jung^ORCID,Kim Jong Woo,Kim Woo Ram^ORCID

Publisher

Elsevier BV

Subject

Surgery

Reference32 articles.

1. Colon Cancer;National Comprehensive Cancer Network,2022

2. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI);Bushati;Eur J Surg Oncol,2018

3. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines;Klaver;Colorectal Dis,2017

4. Richtlijn Colorectaal Carcinoom;Tumoren,2014

5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection;Esquivel;J Gastrointest Oncol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting non-coding RNAs as a promising biomarker in peritoneal metastasis: Background, mechanism, and therapeutic approach;Biomedicine & Pharmacotherapy;2024-10

2. Developing a Core Outcome Set for Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases: A Mixed-Method Study Protocol;Gastrointestinal Disorders;2024-01-18